Public, NASDAQ:QMED
NASDAQ Capital Market
QMed, Inc, Adds Total Population Based Congestive Heart Failure Management to Ohms Technology Platform
Date: Wed, 08 Nov 2000 15:47:00 GMT
Tags:
QMed, Inc, Adds Total Population Based Congestive Heart Failure Management to Ohms Technology Platform
Reuters Key Development - Nov 8, 2000
Reuters Key Development - Nov 8, 2000
FDA Panel Recommends Approval Of DEFLUX in USA
Date: Mon, 23 Oct 2000 16:00:00 GMT
Tags:
QMed, Inc. Announces Use of Ohms|Cad Technology Results in 11.65% Reduction in Stroke in Patients over 65
Date: Fri, 29 Sep 2000 04:00:00 GMT
Tags:
QMed, Inc. Announces Use of Ohms|Cad Technology Results in 11.65% Reduction in Stroke in Patients over 65
Reuters Key Development - Sep 29, 2000
Reuters Key Development - Sep 29, 2000
QMed, Inc. Announces Use of Ohms|Cad System Resulted in 25.8% Reduction in Heart Attacks
Date: Wed, 13 Sep 2000 04:00:00 GMT
Tags:
QMed, Inc. Announces Use of Ohms|Cad System Resulted in 25.8% Reduction in Heart Attacks
Reuters Key Development - Sep 13, 2000
Reuters Key Development - Sep 13, 2000
Q-Med, Inc. Receives FDA Approval for RESTYLANE
Date: Tue, 08 Aug 2000 04:00:00 GMT
Tags:
Yahoo! Finance: RSS feed not found
Date: Tue, 08 Aug 2000 04:00:00 GMT
Tags:
RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.